Company Overview - The Oncology Institute, Inc. (TOI) is one of the largest value-based oncology groups in the United States, founded in 2007 [3] - TOI provides specialized, evidence-based cancer care to over 1.8 million patients, including clinical trials and transfusions, with over 120 employed clinicians and more than 700 staff across 70 clinic locations [3] Leadership Change - Dr. Jeffrey Langsam has been appointed as the Chief Clinical Officer (CCO) of TOI, effective May 13, 2025 [1] - Dr. Langsam previously held significant roles at Cigna Healthcare and Aetna, bringing extensive experience in oncology and specialty pharmacy to TOI [1][2] Strategic Focus - The appointment of Dr. Langsam is expected to enhance TOI's therapeutic decision-making model and support the growth of its Managed Services Organization (MSO) model [2] - The company is experiencing an acceleration in new value-based partnerships and risk-based contracts, positioning it for continued growth in clinical offerings [2]